Clinical Trial Update: Depakote-ER for Depressive and Bipolar Depression [Phase 4]

View source ↗

Summary

Phase 4 trial of Depakote-ER (divalproex sodium) for depressive and bipolar depression has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• DEPAKOTE ER (DIVALPROEX SODIUM)

Snippet

Sponsor: Cambridge Health Alliance | Conditions: Bipolar Disorder | Phase 4 | Status: COMPLETED